E. Kolosionek, B.B. Graham, R.M. Tuder, G. Butrous 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Molecular evolution of Mycobacterium tuberculosis
Patterns of delays in diagnosis amongst patients with smear-positive pulmonary tuberculosis at a teaching hospital in Turkey  E. Okur, A. Yilmaz, A. Saygi,
L. Boyanova  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
Evolution of extended-spectrum β-lactamases by mutation
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
E. Bronska, J. Kalmusova, O. Dzupova, V. Maresova, P. Kriz, J. Benes 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
C. Loupa, D. Voyatzoglou, H. Papadaki, G. Kouppari, G. Saroglou 
Genital Chlamydia trachomatis infections
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
An eye-catching acanthocephalan
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Cutaneous sporotrichosis: the old iodide treatment remains effective
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
Isospora belli Clinical Microbiology and Infection
B. Gordts  Clinical Microbiology and Infection 
CMI editorial report 2011 Clinical Microbiology and Infection
The clinical efficacy of triclosan/copolymer and other common therapeutic approaches to periodontal health  R.M. Davies  Clinical Microbiology and Infection 
Bacterial resistance—the clinical challenge
Elements of design: the knowledge on which we build
Coupled microbial and human systems: evidence for a relationship between infectious disease and gross national product  T.G. Bromage  Clinical Microbiology.
Levofloxacin in the treatment of ventilator-associated pneumonia
Acute schistosomiasis, a diagnostic and therapeutic challenge
Metagenomics and probiotics
Laboratory diagnosis of Clostridium difficile disease
Symposia and Oral Presentations
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Clinical microbiological case: refractory chest wall infection following reconstructive surgery in a patient with relapsed lung cancer  A. Safdar, M.
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
P.M. Hawkey  Clinical Microbiology and Infection 
Current experience in treating invasive zygomycosis with posaconazole
Reducing antibiotic use in influenza: challenges and rewards
Antimicrobial drug development – the past, the present, and the future
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Listeriosis: a resurgent foodborne infection
Clinical Microbiology and Infection
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
C.P. Kelly  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
B.A. Cunha  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Pulmonary vascular disease associated with parasitic infection—the role of schistosomiasis  E. Kolosionek, B.B. Graham, R.M. Tuder, G. Butrous  Clinical Microbiology and Infection  Volume 17, Issue 1, Pages 15-24 (January 2011) DOI: 10.1111/j.1469-0691.2010.03308.x Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 A chest radiograph of a 52-year-old man with schistosomiasis-associated pulmonary arterial hypertension, resulting in right ventricular hypertrophy and a dilated pulmonary trunk. Reproduced with permission from Safwat, PVRI Review 2009; 1: 139 [134]. Clinical Microbiology and Infection 2011 17, 15-24DOI: (10.1111/j.1469-0691.2010.03308.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Representative pulmonary pathology from a patient who died of schistosomiasis-associated pulmonary arterial hypertension. (a) Medial hypertrophy (arrows). (b) Plexiform lesion (white arrowheads). (c) Eccentric intimal thickening (black arrowheads) and a dilated or angiomatoid lesion (star). (d) Pigment (white arrows) adjacent to intimal thickening (black arrowheads). All scale bars are 100 μm. Clinical Microbiology and Infection 2011 17, 15-24DOI: (10.1111/j.1469-0691.2010.03308.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions